Clinical trial
A Cohort Study of Prognostic Factors in Lung Cancer Patients With Malignant Pleural Effusion (MPE).
NCT03276715 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Cohort Study of Prognostic Factors in Lung Cancer Patients With Malignant Pleural Effusion (MPE).
- Lead sponsor
- The University of Hong Kong
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 1, 2016
- Completion date
- October 1, 2018
- Enrollment
- 233 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer, pleural effusion, malignant